Broadcast

e-SPACE CRM 2026 – Day Two

Shelley Zieroth, Shahzeb Khan, João Pedro Ferreira

Broadcast

e-SPACE CRM 2026 – Day One

Shelley Zieroth, Shahzeb Khan, João Pedro Ferreira

About

The high prevalence and increasing incidence of obesity and associated cardiovascular risk emphasises the need to focus on obesity reduction in this high-risk population.

Metabolic syndrome (MetS) is the coexistence of obesity-related cardiovascular risk factors including hypertension, diabetes and dyslipidaemia. MetS is a precursor for atherosclerosis, including premature coronary artery disease, and cardiovascular mortality.
 

Articles

GLP-1RA in Different HFpEF Phenotypes

Published:

16 October 2024

Citation:

Cardiac Failure Review 2024;10:e14.

Heart Failure in South Asians

Published:

16 July 2024

Citation:

Cardiac Failure Review 2024;10:e07.

New Insights on HFpEF Treatment

Published:

03 April 2024

Citation:

Cardiac Failure Review 2024;10:e05.

Epicardial Fat in HFpEF: Correlation or Causation?

Published:

15 April 2023

Citation:

Cardiac Failure Review 2023;9:e06.